Home › Compare › INDFF vs ABBV
INDFF yields 2.58% · ABBV yields 3.12%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, INDFF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INDFF + ABBV for your $10,000?
Indofood Agri Resources Ltd., together with its subsidiaries, operates as a vertically integrated agribusiness company in Singapore, Indonesia, China, Nigeria, Timor Leste, Germany, the Philippines, Myanmar, and internationally. It engages in the research and development; oil palm seed breeding; oil palm cultivation and milling; crude palm oil production and refining; rubber, sugar cane, cocoa, and tea cultivation; and industrial timber plantation activities. The company operates in two segments, Plantations, and Edible Oils and Fats. The Plantations segment is involved in the development and maintenance of oil palm, rubber, and sugar cane plantations; and other business activities relating to processing, marketing, and selling palm oil, rubber, and sugar cane. The Edible Oils and Fats segment produces, markets, and sells edible oil, margarine, shortening, and other related products, as well as its derivative products. It offers cooking oil under the Bimoli, Bimoli Spesial, Delima, Amanda, and Happy brands; and margarine and shortening products under the Amanda, Palmia, Royal Palmia, Simas, Malinda, and Delima brands. As of December 31, 2021, the company had a planted area of approximately 300,749 hectares, including 250,615 hectares of oil palm; 16,228 hectares of rubber; 14,411 hectares of sugar cane; and 19,495 hectares of other crops. It also owns and operates bulking facilities; provides transportation, investment, management, and technical services; and operates in the macronutrients mix fertilizers and prefabrication industries. The company was incorporated in 2001 and is headquartered in Singapore. Indofood Agri Resources Ltd. is a subsidiary of Indofood Singapore Holdings Pte. Ltd.
Full INDFF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.